Author： Temsamani J. Pari G.S. Guinot P.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.9, 1997-09, pp. : 1157-1168
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antisense Oligonucleotides for the Treatment of Dyslipidemia
Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. :
Access to resources
Recommend
Antisense oligonucleotides as drugs for HIV treatment
By Galderisi U Cipollaro M Cascino A
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 10, 2001-10 ,pp. :
Antisense strategies for the treatment of neurological disease
By Stoessl A.J.
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. :
Making Sense of AntisenseA New Approach to Cancer Therapy
Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 2, 2003-01 ,pp. :